Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

We use cookies and similar technologies to make our website work, run analytics, improve our website, and show you personalized content and advertising. Some of these cookies are essential for our website to work. For others, we won’t set them unless you accept them. To find out more about cookies and how to manage cookies, read our Cookie Policy.

Biologics Resources

Find information about our functional bioassays for biologic drug discovery. View scientific presentations and posters with the latest technology and data to help with your research needs.

Join us at these virtual events to learn more about our latest Biologics products and applications:

BEBPA US, March 22-25
CASSS Bioassays, April 19-23
AACR, April 10-15, May 17-21
PEGS Boston, May 11-13
TCR Based Therapies Summit, June 8-10

See lists of peer-reviewed publications that used our reporter bioassays for viral vaccine research and immunotherapy drug development assays including mAb therapeutics, bispecific antibodies, oncolytic virus therapy, cancer vaccines, gene therapy and biosimilars.

Bioassays for BiologicsViral Vaccine Development

Scientific Posters


Developing a Bioluminescent PBMC ADCC Assay for the Discovery and Characterization of Therapeutic Antibodies
Presented by Jey Cheng, Sr. Research Scientist

Download PDF

jamison-grailer-125 Cell-Based Reporter Bioassays for Development of Fc-Functional and Fc-Silent SIRPa/CD47 Checkpoint Inhibitors

Presented by Jamison Grailer, Sr Research Scientist

Download PDF


Quantitative Cell-Based Bioassays to Advance Immunotherapy Programs Targeting Immune Checkpoint Receptors
Presented by Jamison Grailer, Sr Research Scientist

Download PDF

jeff-nelson-125x125 A No-Wash, Rapid FcRn Binding Immunoassay to Guide the Design and Development of Antibody Therapeutics

Presented by Jeff Nelson, Product Manager

Download PDF

New Products

PBMC ADCC Bioassay

Perform your ADCC method bridging studies with the new PBMC ADCC Bioassay, featuring pre-qualified PBMCs. The assay offers improved consistency and robustness for measuring ADCC. Each assay includes ADCC-qualified PBMC effector cells and a choice of popular target cells expressing a HiBiT fusion protein. The simple, add-mix-read format uses bioluminescent detection for maximum sensitivity.

Learn More
In this video interview, Senior Research Scientist Jey Cheng answers common questions about the PBMC ADCC Bioassay.

Lumit™ Immunoassays

Replace conventional immunoassays, such as Western blots and ELISAs, with new Lumit™ Immunoassays. These assays offer direct luminescence measurement in cell culture, broad dynamic range, and can be completed in as little as 30 minutes.

Lumit™ Immunoassays are available for a range of applications, including protein phosphorylation and pathway analysis, FcRn binding, cytokine detection, metabolite research, and more. You can also build your own Lumit™ immunoassays with our labeling and detection kits.

Learn More

Lumit immunoassay principle

General principle of a Lumit™ Immunoassay. Antibodies are chemically labeled with the small and large subunits of NanoLuc® Luciferase, known as SmBiT and LgBiT, respectively. In the presence of an analyte, the two antibodies come into close proximity, allowing SmBiT and LgBiT to form an active enzyme and generate a bright luminescence signal.